Exact Mass: 551.4189

Exact Mass Matches: 551.4189

Found 159 metabolites which its exact mass value is equals to given mass value 551.4189, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Aliskiren

(2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide

C30H53N3O6 (551.3934)


Aliskiren is only found in individuals that have used or taken this drug. It is a renin inhibitor. It was approved by the U.S. Food and Drug Administration in 2007 for the treatment of hypertension.Renin is secreted by the kidney in response to decreases in blood volume and renal perfusion. Renin cleaves angiotensinogen to form the inactive decapeptide angiotensin I (Ang I). Ang I is converted to the active octapeptide angiotensin II (Ang II) by angiotensin-converting enzyme (ACE) and non-ACE pathways. Ang II is a powerful vasoconstrictor and leads to the release of catecholamines from the adrenal medulla and prejunctional nerve endings. It also promotes aldosterone secretion and sodium reabsorption. Together, these effects increase blood pressure. Ang II also inhibits renin release, thus providing a negative feedback to the system. This cycle, from renin through angiotensin to aldosterone and its associated negative feedback loop, is known as the renin-angiotensin-aldosterone system (RAAS). Aliskiren is a direct renin inhibitor, decreasing plasma renin activity (PRA) and inhibiting the conversion of angiotensinogen to Ang I. Whether aliskiren affects other RAAS components, e.g., ACE or non-ACE pathways, is not known. All agents that inhibit the RAAS, including renin inhibitors, suppress the negative feedback loop, leading to a compensatory rise in plasma renin concentration. When this rise occurs during treatment with ACE inhibitors and ARBs, the result is increased levels of PRA. During treatment with aliskiren, however, the effect of increased renin levels is blocked, so that PRA, Ang I and Ang II are all reduced, whether aliskiren is used as monotherapy or in combination with other antihypertensive agents. PRA reductions in clinical trials ranged from approximately 50\\%-80\\%, were not dose-related and did not correlate with blood pressure reductions. The clinical implications of the differences in effect on PRA are not known. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09X - Other agents acting on the renin-angiotensin system > C09XA - Renin-inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

LysoPC(20:0/0:0)

(2-{[(2R)-2-hydroxy-3-(icosanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C28H58NO7P (551.3951)


LysoPC(20:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:0), in particular, consists of one chain of arachidic acid at the C-1 position. The arachidic acid moiety is derived from peanut oil. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(20:0/0:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:0/0:0), in particular, consists of one chain of arachidic acid at the C-1 position. The arachidic acid moiety is derived from peanut oil. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.

   

(2-Acetyloxy-3-octadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-{[2-(acetyloxy)-3-(octadecyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C28H58NO7P (551.3951)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Phosphatidylcholine lyso 20:0

Phosphatidylcholine lyso 20:0

C28H58NO7P (551.3951)


   

(2R)-3-(3-Hydroxy-3-methyl-1-oleoyloxybut-2-yl)-6-(3-methyl-2-butenyl)indole|oleic acid (R)-3-hydroxy-3-methyl-2-<6-(3-methyl-2-butenyl)indole-3-yl>butyl ester

(2R)-3-(3-Hydroxy-3-methyl-1-oleoyloxybut-2-yl)-6-(3-methyl-2-butenyl)indole|oleic acid (R)-3-hydroxy-3-methyl-2-<6-(3-methyl-2-butenyl)indole-3-yl>butyl ester

C36H57NO3 (551.4338)


   

2-[[14-methyl-3-(13-methyltetradec-4-enoyloxy)pentadecanoyl]amino]acetic acid

2-[[14-methyl-3-(13-methyltetradec-4-enoyloxy)pentadecanoyl]amino]acetic acid

C33H61NO5 (551.4549)


   

Antibiotic M 4365G1

Antibiotic M 4365G1

C31H53NO7 (551.3822)


   

1-Stearyl-2-O-acetyl-3-glyceryl phosphorylcholine

1-Stearyl-2-O-acetyl-3-glyceryl phosphorylcholine

C28H58NO7P (551.3951)


   

Butanoyl PAF

1-O-hexadecyl-2-O-butanoyl-sn-glyceryl-3-phosphocholine

C28H58NO7P (551.3951)


   

Aliskiren

(2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide

C30H53N3O6 (551.3934)


C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09X - Other agents acting on the renin-angiotensin system > C09XA - Renin-inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3123

   

PC(O-16:0/4:0)

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-(1-oxobutoxy)-, inner salt, 4-oxide, (R)-

C28H58NO7P (551.3951)


   

PC(O-16:0/4:0)[U]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-(1-oxobutoxy)-, inner salt, 4-oxide, (1)-

C28H58NO7P (551.3951)


   

C18-PAF

1-O-Octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine

C28H58NO7P (551.3951)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Ro 15-4454

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (S)-

C28H58NO7P (551.3951)


   

Platelet-activating factor

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide

C28H58NO7P (551.3951)


   

PC(2:0/O-18:0)[S]

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 7-[(acetyloxy)methyl]-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (S)-

C28H58NO7P (551.3951)


   

PC(2:0/O-18:0)[U]

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 7-[(acetyloxy)methyl]-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide

C28H58NO7P (551.3951)


   

PC(O-16:0/O-5:0)[U]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-(pentyloxy)-, inner salt, 4-oxide

C29H62NO6P (551.4315)


   

PC(O-20:0/O-1:0)

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, inner salt, 4-oxide

C29H62NO6P (551.4315)


   

PC(20:0/0:0)

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-

C28H58NO7P (551.3951)


   

PC(20:0/0:0)[U]

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (1)-

C28H58NO7P (551.3951)


   

PAF C-18

1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine

C28H58NO7P (551.3951)


   

LPC(20:0)

1-Arachidonyl-glycero-3-phosphocholine

C28H58NO7P (551.3951)


   

PC(2:0/O-18:0)

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 7-[(acetyloxy)methyl]-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

C28H58NO7P (551.3951)


   

NA 33:3;O4

N-(14-methyl-3S-(13-methyl-4Z-tetradecenoyloxy)-pentadecanoyl)-glycine

C33H61NO5 (551.4549)


   

PC O-20:0

1-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine

C28H58NO7P (551.3951)


   

LPC 20:0

1-eicosanoyl-sn-glycero-3-phosphocholine

C28H58NO7P (551.3951)


   
   

C34-carboxyphthiodiolenone

C34-carboxyphthiodiolenone

C34H63O5- (551.4675)


   

(4R,5S,6S,7S,9R,11E,13E,15S,16R)-6-[(2R,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,16-diethyl-4-hydroxy-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

(4R,5S,6S,7S,9R,11E,13E,15S,16R)-6-[(2R,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,16-diethyl-4-hydroxy-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C31H53NO7 (551.3822)


   

2-[[3-(Decanoylamino)-2-decoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-(Decanoylamino)-2-decoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

(2-Hydroxy-3-icosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hydroxy-3-icosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C28H58NO7P (551.3951)


   
   
   

NAGly 21:1/10:0

NAGly 21:1/10:0

C33H61NO5 (551.4549)


   

NAGly 17:1/14:0

NAGly 17:1/14:0

C33H61NO5 (551.4549)


   

NAGly 10:0/21:1

NAGly 10:0/21:1

C33H61NO5 (551.4549)


   

NAGly 14:1/17:0

NAGly 14:1/17:0

C33H61NO5 (551.4549)


   

NAGly 13:0/18:1

NAGly 13:0/18:1

C33H61NO5 (551.4549)


   

NAGly 18:1/13:0

NAGly 18:1/13:0

C33H61NO5 (551.4549)


   

NAGly 18:0/13:1

NAGly 18:0/13:1

C33H61NO5 (551.4549)


   

NAGly 16:1/15:0

NAGly 16:1/15:0

C33H61NO5 (551.4549)


   

NAGly 14:0/17:1

NAGly 14:0/17:1

C33H61NO5 (551.4549)


   

NAGly 11:0/20:1

NAGly 11:0/20:1

C33H61NO5 (551.4549)


   

NAGly 12:0/19:1

NAGly 12:0/19:1

C33H61NO5 (551.4549)


   

NAGly 19:1/12:0

NAGly 19:1/12:0

C33H61NO5 (551.4549)


   

NAGly 15:1/16:0

NAGly 15:1/16:0

C33H61NO5 (551.4549)


   

NAGly 20:1/11:0

NAGly 20:1/11:0

C33H61NO5 (551.4549)


   

NAGly 17:0/14:1

NAGly 17:0/14:1

C33H61NO5 (551.4549)


   

NAGly 16:0/15:1

NAGly 16:0/15:1

C33H61NO5 (551.4549)


   

NAGly 13:1/18:0

NAGly 13:1/18:0

C33H61NO5 (551.4549)


   

NAGly 15:0/16:1

NAGly 15:0/16:1

C33H61NO5 (551.4549)


   

2-Aminoethyl (2-hydroxy-3-tetracosoxypropyl) hydrogen phosphate

2-Aminoethyl (2-hydroxy-3-tetracosoxypropyl) hydrogen phosphate

C29H62NO6P (551.4315)


   

(3-Henicosoxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Henicosoxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C29H62NO6P (551.4315)


   

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tricosanoate

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tricosanoate

C28H58NO7P (551.3951)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide

C36H57NO3 (551.4338)


   

(2-Dodecanoyloxy-3-octoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Dodecanoyloxy-3-octoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C28H58NO7P (551.3951)


   

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]docosa-4,7,10,13,16,19-hexaenamide

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]docosa-4,7,10,13,16,19-hexaenamide

C36H57NO3 (551.4338)


   

(7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]docosa-7,10,13,16,19-pentaenamide

(7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]docosa-7,10,13,16,19-pentaenamide

C36H57NO3 (551.4338)


   

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]octadeca-3,6,9,12,15-pentaenamide

C36H57NO3 (551.4338)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide

C36H57NO3 (551.4338)


   

(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

C36H57NO3 (551.4338)


   

(5Z,8Z,11Z,14Z,17Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]icosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]icosa-5,8,11,14,17-pentaenamide

C36H57NO3 (551.4338)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] acetate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] acetate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] hexanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] hexanoate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] propanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] propanoate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] butanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] butanoate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] tetradecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] tetradecanoate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] octanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] octanoate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] pentadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] pentadecanoate

C28H58NO7P (551.3951)


   

(3-Pentadecoxy-2-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Pentadecoxy-2-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C28H58NO7P (551.3951)


   

(2-Heptanoyloxy-3-tridecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Heptanoyloxy-3-tridecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C28H58NO7P (551.3951)


   

(3-Heptadecoxy-2-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Heptadecoxy-2-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C28H58NO7P (551.3951)


   

(3-Nonoxy-2-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Nonoxy-2-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C28H58NO7P (551.3951)


   

(2-Nonanoyloxy-3-undecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Nonanoyloxy-3-undecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C28H58NO7P (551.3951)


   

(3-Dodecoxy-2-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Dodecoxy-2-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] tridecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] tridecanoate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] dodecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] dodecanoate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] decanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] decanoate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] undecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] undecanoate

C28H58NO7P (551.3951)


   

Cer 20:3;3O/13:0;(2OH)

Cer 20:3;3O/13:0;(2OH)

C33H61NO5 (551.4549)


   

Cer 19:3;3O/14:0;(2OH)

Cer 19:3;3O/14:0;(2OH)

C33H61NO5 (551.4549)


   

Cer 18:3;3O/15:0;(2OH)

Cer 18:3;3O/15:0;(2OH)

C33H61NO5 (551.4549)


   

Cer 21:3;3O/12:0;(2OH)

Cer 21:3;3O/12:0;(2OH)

C33H61NO5 (551.4549)


   

Cer 13:1;3O/20:2;(2OH)

Cer 13:1;3O/20:2;(2OH)

C33H61NO5 (551.4549)


   

(2-Decanoyloxy-3-decoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Decanoyloxy-3-decoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C28H58NO7P (551.3951)


   

4-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-propanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-propanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C31H53NO7 (551.3822)


   

4-[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-pentanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-pentanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C31H53NO7 (551.3822)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] nonanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] nonanoate

C28H58NO7P (551.3951)


   

(2-Hexanoyloxy-3-tetradecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexanoyloxy-3-tetradecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] heptanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] heptanoate

C28H58NO7P (551.3951)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] pentanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] pentanoate

C28H58NO7P (551.3951)


   

Cer 14:2;3O/19:1;(2OH)

Cer 14:2;3O/19:1;(2OH)

C33H61NO5 (551.4549)


   

Cer 19:2;3O/14:1;(2OH)

Cer 19:2;3O/14:1;(2OH)

C33H61NO5 (551.4549)


   

Cer 20:2;3O/13:1;(2OH)

Cer 20:2;3O/13:1;(2OH)

C33H61NO5 (551.4549)


   

Cer 17:2;3O/16:1;(2OH)

Cer 17:2;3O/16:1;(2OH)

C33H61NO5 (551.4549)


   

Cer 18:2;3O/15:1;(2OH)

Cer 18:2;3O/15:1;(2OH)

C33H61NO5 (551.4549)


   

Cer 17:1;3O/16:2;(2OH)

Cer 17:1;3O/16:2;(2OH)

C33H61NO5 (551.4549)


   

Cer 21:2;3O/12:1;(2OH)

Cer 21:2;3O/12:1;(2OH)

C33H61NO5 (551.4549)


   

Cer 15:2;3O/18:1;(2OH)

Cer 15:2;3O/18:1;(2OH)

C33H61NO5 (551.4549)


   

Cer 15:1;3O/18:2;(2OH)

Cer 15:1;3O/18:2;(2OH)

C33H61NO5 (551.4549)


   

lysoDGTS 22:3

lysoDGTS 22:3

C32H57NO6 (551.4186)


   

4-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C31H53NO7 (551.3822)


   

4-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C31H53NO7 (551.3822)


   

2-[Hydroxy-[3-hydroxy-2-(pentadecanoylamino)octoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(pentadecanoylamino)octoxy]phosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[Hydroxy-[3-hydroxy-2-(octanoylamino)pentadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(octanoylamino)pentadecoxy]phosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[Hydroxy-[3-hydroxy-2-(pentanoylamino)octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(pentanoylamino)octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[[2-(Butanoylamino)-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Butanoylamino)-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[[2-(Hexanoylamino)-3-hydroxyheptadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Hexanoylamino)-3-hydroxyheptadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[Hydroxy-[3-hydroxy-2-(undecanoylamino)dodecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(undecanoylamino)dodecoxy]phosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[Hydroxy-[3-hydroxy-2-(nonanoylamino)tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(nonanoylamino)tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[[2-(Dodecanoylamino)-3-hydroxyundecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Dodecanoylamino)-3-hydroxyundecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[Hydroxy-[3-hydroxy-2-(propanoylamino)icosoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(propanoylamino)icosoxy]phosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[[2-(Heptanoylamino)-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Heptanoylamino)-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[[2-(Decanoylamino)-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Decanoylamino)-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[Hydroxy-[3-hydroxy-2-(tetradecanoylamino)nonoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(tetradecanoylamino)nonoxy]phosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[Hydroxy-[3-hydroxy-2-(tridecanoylamino)decoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(tridecanoylamino)decoxy]phosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

2-[(2-Acetamido-3-hydroxyhenicosoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Acetamido-3-hydroxyhenicosoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H60N2O6P+ (551.4189)


   

1-eicosanoyl-sn-glycero-3-phosphocholine

1-eicosanoyl-sn-glycero-3-phosphocholine

C28H58NO7P (551.3951)


   

Platelet activating factor-acether

1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine

C28H58NO7P (551.3951)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

1-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine

1-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine

C28H58NO7P (551.3951)


   

lysophosphatidylcholine 20:0

lysophosphatidylcholine 20:0

C28H58NO7P (551.3951)


A lysophosphatidylcholine in which the remaining acyl group contains 20 carbons and 0 double bonds. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.

   

2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine

2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine

C28H58NO7P (551.3951)


A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine betaine which has octadecyl as the alkyl group. PAF is a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis.

   

1-icosanoyl-sn-glycero-3-phosphocholine

1-icosanoyl-sn-glycero-3-phosphocholine

C28H58NO7P (551.3951)


A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as icosanoyl.

   

MePC(19:0)

MePC(8:0(1)_11:0)

C28H58NO7P (551.3951)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Cer(36:8)

Cer(d14:2_22:6)

C36H57NO3 (551.4338)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PE(23:0)

PE(8:0(1)_15:0)

C28H58NO7P (551.3951)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   

Cer 14:2;O2/22:6

Cer 14:2;O2/22:6

C36H57NO3 (551.4338)


   
   

CerP 14:0;O2/14:0;O

CerP 14:0;O2/14:0;O

C28H58NO7P (551.3951)


   

CerP 15:0;O2/13:0;O

CerP 15:0;O2/13:0;O

C28H58NO7P (551.3951)


   

CerP 16:0;O2/12:0;O

CerP 16:0;O2/12:0;O

C28H58NO7P (551.3951)


   

CerP 17:0;O2/11:0;O

CerP 17:0;O2/11:0;O

C28H58NO7P (551.3951)


   

CerP 18:0;O2/10:0;O

CerP 18:0;O2/10:0;O

C28H58NO7P (551.3951)


   
   

ST 29:1;O5;Gly

ST 29:1;O5;Gly

C31H53NO7 (551.3822)


   

ST 23:0;O2;HexNAc

ST 23:0;O2;HexNAc

C31H53NO7 (551.3822)


   

(2s)-3-hydroxy-3-methyl-2-[5-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl (9z)-octadec-9-enoate

(2s)-3-hydroxy-3-methyl-2-[5-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl (9z)-octadec-9-enoate

C36H57NO3 (551.4338)


   

(2r)-3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl (9z)-octadec-9-enoate

(2r)-3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl (9z)-octadec-9-enoate

C36H57NO3 (551.4338)


   

6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-7,16-diethyl-4-hydroxy-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-7,16-diethyl-4-hydroxy-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C31H53NO7 (551.3822)


   

(11z,13z)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-7,16-diethyl-4-hydroxy-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

(11z,13z)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-7,16-diethyl-4-hydroxy-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C31H53NO7 (551.3822)


   

3-hydroxy-3-methyl-2-[5-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl octadec-9-enoate

3-hydroxy-3-methyl-2-[5-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl octadec-9-enoate

C36H57NO3 (551.4338)


   

(2-{[(2r)-2-hydroxy-3-(icosanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

(2-{[(2r)-2-hydroxy-3-(icosanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C28H58NO7P (551.3951)


   

(3r,6s,9r,12r,15s)-3-isopropyl-6,9,12,15-tetrakis(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

(3r,6s,9r,12r,15s)-3-isopropyl-6,9,12,15-tetrakis(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

C29H53N5O5 (551.4046)


   

(2s)-3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl (9z)-octadec-9-enoate

(2s)-3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl (9z)-octadec-9-enoate

C36H57NO3 (551.4338)


   

3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl octadec-9-enoate

3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl octadec-9-enoate

C36H57NO3 (551.4338)


   

({1-hydroxy-14-methyl-3-[(13-methyltetradec-4-enoyl)oxy]pentadecylidene}amino)acetic acid

({1-hydroxy-14-methyl-3-[(13-methyltetradec-4-enoyl)oxy]pentadecylidene}amino)acetic acid

C33H61NO5 (551.4549)


   

{[(3s)-1-hydroxy-14-methyl-3-{[(4z)-13-methyltetradec-4-enoyl]oxy}pentadecylidene]amino}acetic acid

{[(3s)-1-hydroxy-14-methyl-3-{[(4z)-13-methyltetradec-4-enoyl]oxy}pentadecylidene]amino}acetic acid

C33H61NO5 (551.4549)


   

(4r,5s,6s,7s,9r,11e,13e,15s,16r)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-7,16-diethyl-4-hydroxy-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

(4r,5s,6s,7s,9r,11e,13e,15s,16r)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-7,16-diethyl-4-hydroxy-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C31H53NO7 (551.3822)